<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Sinclair, Heather Q.</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Lewandowski, Christopher</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Acute Stroke and the tPA Dilemma</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2010</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2010-03-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">33-34</style></pages><abstract><style  face="normal" font="default" size="100%">There is some uncertainty regarding the appropriate treatment strategy for mild stroke and whether or not thrombolytic therapy with tissue plasminogen activator (tPA) is suitable for less severe stroke patients. This article discusses methods for distinguishing stroke mimics from stroke and the ramifications of tPA in stroke mimics.</style></abstract><number><style face="normal" font="default" size="100%">1</style></number><volume><style face="normal" font="default" size="100%">10</style></volume></record></records></xml>